Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05850676 · ClinicalTrials.gov registry record
Disentangling the Role of Depression in Hypersomnia
A clinical trial of Hypersomnia, sponsored by University of Pennsylvania.
- Recruiting
- Registry status
- 45
- Enrollment target
- 1
- Study location
NCT05850676 is a study of Hypersomnia that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 45 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05850676, a study of Hypersomnia, is actively recruiting participants, sponsored by University of Pennsylvania.
- RECRUITING
- Registry status
- 45 participants
- Enrollment target
- 1
- Study location
Study Summary
Individuals who have disorders of hypersomnolence (excessive sleepiness) often report symptoms of depression. The goal of this study is to further understand of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward function.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Sleep study
Study Locations (1)
Pennsylvania
- The University of Pennsylvania - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2023-08-01 |
| Est. Completion | 2026-06-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05850676
The ClinicalTrials.gov registry entry for NCT05850676 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 45 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Hypersomnia appearing as the primary indexed condition, and to 1 intervention - of which Sleep study is the first listed.
NCT05850676 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05850676 about?
NCT05850676 is a clinical study titled "Disentangling the Role of Depression in Hypersomnia". Individuals who have disorders of hypersomnolence (excessive sleepiness) often report symptoms of depression. The goal of this study is to further understand of the relationship between depression and hypersomnia by examining mood-relevant domains of slow wave sleep and reward function.
What is the current status of trial NCT05850676?
This trial is currently recruiting. The enrollment target is 45 participants. The study started on 2023-08-01. Estimated completion is 2026-06-30.
What conditions does trial NCT05850676 study?
This clinical trial studies the following conditions: Hypersomnia.
What interventions are being tested in trial NCT05850676?
The interventions under investigation include: Sleep study (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05850676?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05850676 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypersomnia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.